Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase I
IMV Inc. to Present at Upcoming Investor Conference
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San…
Phase I
Roche Vice Chairman Calls for Long-Term Thinking by Business to Save…
Approval
Marizyme Agrees to Distribute Somahlution’s DuraGraft Products in South America and…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low…
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove…
Commercial
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Commercial
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim…
Home
Commercial
Financial
Financial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Financial
ChromaDex Statement Regarding the October 9th Order in the Central District of California Litigation
Biospace News
-
October 11, 2019
Financial
Galderma Advances Phase 3 Clinical Study with Nemolizumab in Moderate-to-Severe Atopic Dermatitis
Financial
Boehringer Ingelheim Gambles $2.62 Billion on Two Fibrotic Disease Deals
Financial
Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results
Financial
The Medicines Company to Announce Second Quarter 2019 Financial Results on July 24
Financial
Cytori Will Become Plus Therapeutics, Inc.
Firstwordpharma News
-
July 16, 2019
0
Financial
Kite Announces Plans to Bolster Industry-Leading Cell Therapy Manufacturing Capabilities With...
Biospace News
-
July 16, 2019
0
Financial
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results –...
Biospace News
-
July 15, 2019
0
Financial
NovaBay Pharmaceuticals Issues Letter to Stockholders
Biospace News
-
July 15, 2019
0
Financial
Poxel Reports Financial Update for Cash and Revenue for the Second...
Biospace News
-
July 15, 2019
0
1
2
3
...
77
Page 1 of 77
- Advertisement -
MOST POPULAR
May 2019 decisions news release
May 13, 2019
Avion Pharmaceuticals, LLC, and ROMEG Therapeutics, LLC, finalize partnership agreement to...
July 16, 2019
PCMA: Greater Competition on Insulin Products Key to Reducing Prices
April 10, 2019
Lyfebulb and Celgene Announce Finalists for 2019 “Addressing Unmet Needs in...
May 10, 2019
Load more
HOT NEWS
Deals
Avion Pharmaceuticals, LLC, and ROMEG Therapeutics, LLC, finalize partnership agreement to...
Phase III
Soleno Therapeutics Announces Positive Outcome from Planned Data Safety Monitoring Board...
Phase II
Results from the EDCR IIa trial where Diamyd is given subcutaneously
Financial
$74 Billion BMS-Celgene Deal Gets Support From Proxy Advisory Firm ISS
